Showing results (61-70 of 332) with videos related to
Sort By:
Pageof 34
Journal of Neurology|October 21, 2023
Identification and management of subclinical disease activity in early multiple sclerosis: a reviewDaniel Ontaneda, Tanuja Chitnis, Kottil Rammohan, et al.Clinical Neurology and Neurosurgery|April 21, 2006
Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndromeLaura Ordonez, Eli Skromne, Daniel Ontaneda, et al.Neurology. Clinical Practice|August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centersBrandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.Multiple Sclerosis and Related Disorders|July 27, 2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trialsTobias Derfuss, Daniel Ontaneda, Jacqueline Nicholas, et al.Current Neurology and Neuroscience Reports|June 28, 2024
Artificial Intelligence and Multiple SclerosisMoein Amin, Eloy Martínez-Heras, Daniel Ontaneda, et al.Multiple Sclerosis and Related Disorders|August 3, 2025
Cognitive profiles associated with faster thalamic atrophy in multiple sclerosisMoein Amin, Keeley Scullin, Kunio Nakamura, et al.Multiple Sclerosis and Related Disorders|August 25, 2019
Vitamin D and MRI measures in progressive multiple sclerosisJustin R Abbatemarco, Robert J Fox, Hong Li, et al.Current Neurology and Neuroscience Reports|June 16, 2010
Emerging oral therapies in multiple sclerosisDevon Conway, Jeffrey A CohenMuscle & Nerve|September 5, 2002
Clinical variant of familial amyloid polyneuropathyDianna Quan, Jeffrey A CohenAnnals of Neurology|April 27, 2011
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosisJeffrey A Cohen, Jerold ChunPageof 34